Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1982;65:918-923

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, J. T.
Right arrow Articles by Cobb, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, J. T.
Right arrow Articles by Cobb, F. R.

Circulation, Vol 65, 918-923, Copyright © 1982 by American Heart Association


ARTICLES

Myocardial infarct extension: incidence and relationship to survival

JT Baker, DA Bramlet, RM Lester, DG Harrison, CR Roe and FR Cobb

Myocardial infarct extension, defined as reelevation or reappearance of creatine phosphokinase-MB (CK-MB) 48 hours after the onset of symptoms, was evaluated prospectively in 56 consecutive patients with acute myocardial infarction. Myocardial infarct extension occurred in eight patients (14%). The sensitivity, specificity and predictive accuracy in the diagnosis of myocardial infarct extension were 63%, 85% and 42%, respectively, for recurrent chest pain requiring morphine; 50%, 65% and 19% for recurrent ST-segment elevation on routine 12-lead ECGs; and 88%, 63% and 28% for reelevation of total CK. Three of the eight episodes of extension were clinically silent. Four of eight patients (50%) with extension died, compared with one of 46 patients (2%) without extension (p = 0.0009). CK-MB persisted for 72 hours or longer in 16 patients and identified seven of eight patients who subsequently had infarct extension. We conclude that myocardial infarct extension is an infrequent complication of acute myocardial infarction and is associated with a very high mortality rate. Persistence of CK-MB for 72 hours or more identifies a subgroup of patients at high risk for subsequent infarct extension and death.


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
J. E. MULLER, R. E. RUDE, E. BRAUNWALD, T. D. HARTWELL, R. ROBERTS, B. E. SOBEL, C. RITTER, C. B. PARKER, A. S. JAFFE, P. H. STONE, et al.
Myocardial Infarct Extension: Occurrence, Outcome, and Risk Factors in the Multicenter Investigation of Limitation of Infarct Size
Ann Intern Med, January 1, 1988; 108(1): 1 - 6.
[Abstract] [PDF]